Format

Send to

Choose Destination
Microbes Infect. 2002 Oct;4(12):1219-25.

Global epidemiology and burden of hepatitis C.

Author information

1
Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic and Foundation, 200 First Street, SW, Rochester, MN 55905, USA. kim.wong@mayo.edu

Abstract

Despite rapid progress in our knowledge of hepatitis C virology and pathogenesis, little is known about the current and future burden of this infection throughout the world. Prevalence and population-based studies have suggested that complications of the liver disease associated with chronic hepatitis C infection may potentially require substantial health care resources and generate very high costs for medical systems in the United States, Europe and worldwide. Careful understanding and assessment of hepatitis C health and economic burdens are likely to guide better programs for the management of infected individuals and the prevention of complications.

PMID:
12467763
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center